Advisor Group Holdings, Inc. Eli Lilly & CO Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 198,464 shares of LLY stock, worth $150 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

198,464

Previous 203,397 2.43%

Holding current value

$150 Million

Previous $184 Million 4.52%

% of portfolio

0.42%

Previous 0.45%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $3.81 Million - $4.74 Million	-4,933 Reduced 2.43%	198,464 $176 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $13.4 Million - $16.8 Million	-18,428 Reduced 8.31%	203,397 $184 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $29.9 Million - $40 Million	-50,515 Reduced 18.55%	221,825 $173 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $45.3 Million - $53.4 Million	-86,225 Reduced 24.05%	272,340 $159 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $40.9 Million - $56.4 Million	94,140 Added 35.6%	358,565 $193 Million
Q2 2023 Aug 21, 2023	SELL	$350.74 - $468.98 $52.2 Million - $69.8 Million	-148,818 Reduced 36.01%	264,425 $124 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $49.3 Million - $65.9 Million	140,606 Added 51.57%	413,243 $194 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $2.05 Million - $2.41 Million	-6,609 Reduced 2.37%	272,637 $93.6 Million
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $6.2 Million - $7.23 Million	19,297 Added 7.42%	279,246 $102 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $5.46 Million - $6.23 Million	18,425 Added 7.63%	259,949 $84.1 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $7.92 Million - $9.3 Million	28,422 Added 13.34%	241,524 $78.4 Million
Q1 2022 May 04, 2022	BUY	$234.69 - $291.66 $6.22 Million - $7.73 Million	26,512 Added 14.21%	213,102 $58.1 Million
Q3 2021 Nov 05, 2021	BUY	$221.6 - $272.71 $3.12 Million - $3.84 Million	14,071 Added 8.16%	186,590 $43.1 Million
Q2 2021 Aug 02, 2021	BUY	$180.55 - $233.54 $21,666 - $28,024	120 Added 0.07%	172,519 $39.6 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $388,945 - $503,508	-2,367 Reduced 1.35%	172,399 $32.2 Million
Q4 2020 Feb 10, 2021	SELL	$130.46 - $172.63 $1.13 Million - $1.5 Million	-8,666 Reduced 4.72%	174,766 $29.5 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $692,936 - $801,507	4,739 Added 2.65%	183,432 $27.3 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $64 Million - $77 Million	-469,114 Reduced 72.42%	178,693 $29.4 Million
Q1 2020 May 18, 2020	BUY	$119.05 - $147.35 $77.1 Million - $95.5 Million	647,807 New	647,807 $23.7 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Eli Lilly & CO Transaction History